Diabetes is one of the strongest risk factors for coronary disease, Pedro Lemos (Hospital Israelita Albert Einstein, São Paulo, Brazil) tells Cardiovascular News, discussing his strategies for managing the treatment of diabetic patients in the cath lab.
In this interview, he explains why using a drug-coated balloon (DCB) may be an appealing option when it comes to the treatment of coronary artery disease, particularly among a subset of patients who are at high risk for restenosis.
There are no signals of any safety issues when it comes to using DCBs in these patients, Lemos explains, and the rate of restenosis has been shown to be “at least” as good as when using a drug-eluting stent (DES). “The signal is there, and it is very clear, DCBs for diabetes are at least as safe and as effective as DES, if not better,” Lemos says.
This video is sponsored by B Braun Melsungen AG.
